Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.090
-0.015 (-0.48%)
Feb 27, 2026, 3:20 PM EST - Market open
Adagene Market Cap
Adagene has a market cap or net worth of $145.64 million as of February 27, 2026. Its market cap has increased by 90.15% in one year.
Market Cap
145.64M
Enterprise Value
91.54M
1-Year Change
90.15%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $145.64M, a decrease of -81.89%. That is a compound annual growth rate of -28.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 146.34M | 64.29% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 158.64M |
| Zentalis Pharmaceuticals | 154.43M |
| Corbus Pharmaceuticals Holdings | 153.97M |
| Polaryx Therapeutics | 150.08M |
| Unicycive Therapeutics | 148.51M |
| Artiva Biotherapeutics | 145.06M |
| Black Diamond Therapeutics | 140.73M |
| Oramed Pharmaceuticals | 139.31M |